case_images: PMC9379108_01
case_images: Front view before injecting filler.
case_images: CCID-15-1627-g0001.jpg
case_images: PMC9379108_01_CCID-15-1627-g0001.jpg
case_images: f0001
case_images: There were no signs of reactivation of the disease at the 1 year of follow-up (Figures 1-6).
case_images: Profile view before injecting filler.
case_images: CCID-15-1627-g0002.jpg
case_images: PMC9379108_01_CCID-15-1627-g0002.jpg
case_images: f0002
case_images: There were no signs of reactivation of the disease at the 1 year of follow-up (Figures 1-6).
case_images: Front view after injecting 1ml of filler.
case_images: CCID-15-1627-g0003.jpg
case_images: PMC9379108_01_CCID-15-1627-g0003.jpg
case_images: f0003
case_images: There were no signs of reactivation of the disease at the 1 year of follow-up (Figures 1-6).
case_images: Profile view after injecting 1ml of filler.
case_images: CCID-15-1627-g0004.jpg
case_images: PMC9379108_01_CCID-15-1627-g0004.jpg
case_images: f0004
case_images: There were no signs of reactivation of the disease at the 1 year of follow-up (Figures 1-6).
case_images: Front view after injecting 2nd ml of filler.
case_images: CCID-15-1627-g0005.jpg
case_images: PMC9379108_01_CCID-15-1627-g0005.jpg
case_images: f0005
case_images: There were no signs of reactivation of the disease at the 1 year of follow-up (Figures 1-6).
case_images: Profile view after injecting 2nd ml of filler.
case_images: CCID-15-1627-g0006.jpg
case_images: PMC9379108_01_CCID-15-1627-g0006.jpg
case_images: f0006
case_images: There were no signs of reactivation of the disease at the 1 year of follow-up (Figures 1-6).